drugset / Trial / NCT00365170

Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

NCT00365170

Phase 4 Completed 419 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

This trial was conducted in Europe, Middle East, North America and South America. The aim of this trial was to compare the use of an intensified insulin treatment with insulin aspart (NovoRapid®) versus human insulin (Actrapid®) in pregnancy.

Timeline

Start
2002-09
Primary completion
2005-04
Completion
2005-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic
Subject insulin aspart Protein / enzyme biologic